Etanercept (Enbrel) in Undifferentiated Spondyloarthritis
Status:
Unknown status
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The study has the aim to investigate the efficacy and safety of etanercept in patients with
active undifferentiated spondyloarthritis (uSpA) over the period of 520 weeks.